Journal
TRENDS IN PHARMACOLOGICAL SCIENCES
Volume 36, Issue 5, Pages 310-320Publisher
ELSEVIER SCIENCE LONDON
DOI: 10.1016/j.tips.2015.03.001
Keywords
angiotensin-(1-7); renin-angiotensin system; angiotensin II; cancer; Mas receptor
Categories
Funding
- FONDECYT [1110426]
- CARE [PFB12/2007]
Ask authors/readers for more resources
The renin-angiotensin system (RAS) plays a pivotal role in cardiovascular and hydro-electrolyte homeostasis. Blockade of the RAS as a therapeutic strategy for treating hypertension and related cardiovascular diseases is well established. However, actions of the RAS go far beyond the targets initially described. In this regard, the recent identification of novel components of the RAS, including angiotensin-(1-7) [Ang-(1-7)], Ang-(1-9), and alamandine, have opened new possibilities for interfering with the development and manifestations of cardiovascular and non-cardiovascular diseases. In this article, we briefly review novel targets for angiotensins and its therapeutic implications in diverse areas, including cancer, inflammation, and glaucoma.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available